#United States #Nashville #Revance #Melissa O'Connor #Global Regulatory

Revance Announces the Appointment of Melissa O'Connor as Senior Vice President, Global Regulatory

Revance, a rapidly expanding leader in the aesthetics and skincare industry, has made a significant addition to its leadership team with the appointment of Melissa O'Connor as Senior Vice President of Global Regulatory. This strategic move comes as Revance aims to enhance its regulatory framework and ensure its products adhere to the necessary standards while facilitating timely market approvals.

In her new role, Ms. O'Connor will report directly to Nick Crowe, the Chief Operating Officer at Revance. She is tasked with spearheading the company's global regulatory strategies, overseeing interactions with regulatory bodies, and guiding submission processes to mitigate risks associated with regulatory compliance. Ms. O'Connor's extensive experience and expertise are expected to play a crucial role as Revance continues to grow its global presence and expand its product pipeline.

Nadeem Moiz, a key figure at Revance, expressed confidence in Ms. O'Connor's capabilities. He stated, "Melissa brings the depth of regulatory expertise and practical leadership needed as we expand globally and focus on regulatory filings. Her experience across various product categories will bolster our ability to navigate complex regulatory challenges and bring innovations to market efficiently."

Melissa O'Connor boasts over 25 years of experience in the field, particularly in regulatory affairs concerning medical devices, biologics, and combination products. She has been instrumental in crafting successful regulatory strategies that fulfill approval requirements in both the United States and the European Union. Ms. O'Connor holds an active Regulatory Affairs Certification (RAC) and was recognized as a Fellow of the Regulatory Affairs Professionals Society (RAPS) in 2022 — underscoring her dedication to the field.

Before joining Revance, Ms. O'Connor served as the Chief Quality and Regulatory Officer at StimLabs, LLC, where she led initiatives related to quality and regulatory affairs for human tissue-based products and medical devices. Her previous roles at QSpex Technologies and Chemence Medical Products further enriched her comprehensive understanding of regulatory processes. Additionally, her career began as a materials and product development engineer with Kimberly-Clark Healthcare, showcasing her diverse background.

Holding both a B.S. in Biological Sciences and an M.S. in Biomedical and Pharmaceutical Regulatory Affairs from the University of Georgia, Ms. O'Connor is well-equipped with the academic knowledge to complement her extensive practical experience.

About Revance

Revance is not just any skincare company; it is a rapidly growing global entity that focuses on innovative aesthetics and market-focused skincare products. With an impressive array of offerings spanning over 60 countries, Revance is committed to understanding and addressing the evolving needs of its consumers.

The company emphasizes skin science and innovation, featuring a differentiated product portfolio that includes industry-leading brands and cutting-edge technologies. Its acclaimed aesthetic products like DAXXIFY® and the RHA® Collection of dermal fillers, paired with consumer favorites such as PanOxyl® and StriVectin®, highlight Revance's dedication to excellence in skincare.

In conclusion, Melissa O'Connor's appointment marks a pivotal moment for Revance as it strives for continued growth in the global market while ensuring compliance and quality in all its products. Her leadership is expected to steer the company toward timely product approvals and minimize risks associated with regulatory challenges, thereby enhancing Revance's reputation as a leader in the aesthetics and skincare industry.